Speciation of arsenic in urine following intravenous administration of arsthinol in mice

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 35, Issue 1-2, 2010, Pages 59-65

  Ajana, Imane ^a   Astier, Alain ^a   Gibaud, Stéphane ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Arsenic; Arsthinol; LC MS; Speciation; Urine samples

Indexed keywords

ACETARSOL; ACETARSOL OXIDE; ARSTHINOL; MELARSOPROL; ORGANOARSENIC DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY FLUID; CALORIMETRY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; HYDROPHOBICITY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; ORGAN DISTRIBUTION; SINGLE DRUG DOSE; TISSUE DISTRIBUTION; URINALYSIS; URINARY EXCRETION;

ANIMALS; ANTINEOPLASTIC AGENTS; ARSENIC; ARSENICALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; MASS SPECTROMETRY; MICE; OXIDES; URINE;

EID: 78149411705     PISSN: 03787966     EISSN: 21070180     Source Type: Journal    
DOI: 10.1007/s13318-010-0009-6     Document Type: Article

References (18)

1. I Ajana, et al. 2009 Arsthinol nanosuspensions: pharmacokinetics and antileukemic activity on NB4 promyelocytic leukemia cells J Pharm Pharmacol 61 1295 1301 1:CAS:528:DC%2BD1MXhtlWrur3N 10.1211/jpp/61.10.0004 19814860
2. S Ben Zirar, et al. 2007 Pharmacokinetics and tissue distribution of the antileukaemic organoarsenicals arsthinol and melarsoprol in mice J Organomet Chem 692 1348 1352 1:CAS:528:DC%2BD2sXhsF2mu70%3D 10.1016/j.jorganchem.2006.10. 034 (Pubitemid 46209183)
3. BJ Berger AH Fairlamb 1994 Properties of melarsamine hydrochloride (Cymelarsan) in aqueous solution Antimicrob Agents Chemother 38 1298 1302 1:CAS:528:DyaK2cXksValsrc%3D 8092828
4. B Cristau, et al. 1972 Voies et cinétiques d'élimination de l'arsenic chez le rat après administration de médicaments organoarséniés - II. Etude du mélarsoprol et du mélarsonyl potassique Med Trop (Mars) 32 275 283 1:CAS:528: DyaE3sXjslyntA%3D%3D
5. B Cristau, et al. 1973 Elimination biliaire chez le rat de quelques médicaments organoarseniés J Pharmacol 4 199 207 1:CAS:528:DyaE3sXktlynsLk%3D
6. B Cristau, et al. 1975 Voies et cinétiques d'excrétion de l'arsenic chez le Cobaye après injection de divers médicaments organo-arséniés Ann Pharm Fr 33 577 589 1:CAS:528: DyaE28XksFKnu7k%3D 1231604
7. V Devesa, et al. 2004 Comprehensive analysis of arsenic metabolites by pH-specific hydride generation atomic absorption spectrometry J Anal At Spectrom 19 1460 1467 1:CAS:528:DC%2BD2cXpt1OmtL4%3D 10.1039/b407388f
8. SC Elliot BR Loper 1974 Improved absorption tube for arsenic determinations Anal Chem 46 2256 2257 10.1021/ac60350a038
9. C Forkner T Scott 1931 Arsenic as a therapeutic agent in chronic myelogenous leukemia J Am Med Assoc 97 3 5
10. S Gibaud, et al. 2006 (2-Phenyl-[1, 3, 2] dithiarsolan-4-yl)-methanol derivatives show in vitro antileukemic activity J Organomet Chem 691 1081 1084 1:CAS:528:DC%2BD28XhtFGrt78%3D 10.1016/j.jorganchem.2005.11.007 (Pubitemid 43172208)
11. L Goldman, et al. 1956 Arsthinol (Balarsen) in dermatology Dermatologica 113 369 374 1:STN:280:DyaG2s%2FmtVOqsQ%3D%3D 10.1159/000256212 13414432
12. Z Gregus A Gyurasics 2000 Role of glutathione in the biliary excretion of the arsenical drugs trimelarsan and melarsoprol Biochem Pharmacol 59 1375 1385 1:CAS:528:DC%2BD3cXit1Wnurc%3D 10.1016/S0006-2952(00)00263-X 10751546 (Pubitemid 30177354)
13. R Harrison 2002 Structure and function of xanthine oxidoreductase: where are we now? Free Radic Biol Med 33 774 797 1:CAS:528:DC%2BD38Xms1ymt7k%3D 10.1016/S0891-5849(02)00956-5 12208366 (Pubitemid 35232313)
14. MF Hughes, et al. 2003 Accumulation and metabolism of arsenic in mice after repeated oral administration of arsenate Toxicol Appl Pharmacol 191 202 210 1:CAS:528:DC%2BD3sXnt1amurY%3D 10.1016/S0041-008X(03)00249-7 13678653 (Pubitemid 37108684)
15. H Most, et al. 1954 Arsthinol (Balarsen), a new trivalent arsenical for the treatment of intestinal amebiasis and other intestinal protozoa Am J Trop Med Hyg 3 262 265 1:STN:280:DyaG2c%2FlvVOiug%3D%3D 13138828
16. E Pick Y Keisari 1980 A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture J Immunol Methods 38 161 170 1:CAS:528:DyaL3MXnvFKhtg%3D%3D 10.1016/0022-1759(80)90340-3 6778929
17. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients Blood 89 3354 3360 1:CAS:528:DyaK2sXivVymu7o%3D 9129042
18. S Waxman KC Anderson 2001 History of the development of arsenic derivatives in cancer therapy Oncologist 6 3 10 1:CAS:528:DC%2BD3MXktVShsbc%3D 10.1634/theoncologist.6-suppl-2-3 11331434